Abstract
The NCCN Guidelines for Chronic Myeloid Leukemia (CML) criteria for discontinuation of tyrosine kinase inhibitor (TKI) therapy have not seen significa......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
